Nebenwirkungen · Repaglinide Teva
Repaglinide Teva 0.5 mg tablets Repaglinide Teva 1 mg tablets Repaglinide Teva 2 mg tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-210754 · Präparat HOS-154579
Immune system disorders Allergic reactions* Very rare Metabolism and nutrition Hypoglycaemia Common disorders Hypoglycaemic coma and Not known hypoglycaemic unconsciousness Eye disorders Refraction disorder* Very rare Cardiac disorders Cardiovascular disease Rare Gastrointestinal disorders Abdominal pain, diarrhoea Common Vomiting, constipation Very rare Nausea Not known Hepatobiliary disorders Abnormal hepatic function, Very rare increased liver enzymes* Skin and subcutaneous tissue Hypersensitivity* Not known disorders * see section Description of selected adverse reactions below
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-02-11T17:40:00Z · SHA-256 7ea88aaeb62655814b4cbb82e87f581c1d76d8e897c814045f52ed8ce0706612 · Passage b0acfcbd60327d876f3c2f655703b25904257716cdfbb0f086676a1b4aead705 · Zeichen 624–1640 im Abschnitt